Product image of Elocta (Efmoroctocog Alfa) supplied by GNH India

Elocta

Active Ingredient:
Efmoroctocog Alfa
Origin:
EU

Elocta (Efmoroctocog Alfa)

Elocta (Efmorocotocog Alfa) is a recombinant factor VIII replacement therapy for hemophilia A. This intravenous medication is designed to manage and prevent bleeding episodes in adults and children with this condition.

Manufacturer / TM Owner

Swedish Orphan Biovitrum Ab (Publ)

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Elocta is primarily used for the treatment and prevention of bleeding episodes in individuals with hemophilia A, a genetic disorder that impairs blood clotting. It is also used to manage bleeding during surgical procedures. The medication works by replacing the missing clotting factor VIII, which is essential for normal blood coagulation. People often ask, 'What is Elocta used for?' and the answer is that it is specifically formulated to address the clotting deficiencies associated with hemophilia A.

Side Effects

  • Common effects of Elocta may include mild to moderate reactions at the injection site, such as redness, swelling, or itching. Some individuals may experience headaches, nausea, or dizziness. These effects are generally temporary and resolve on their own. It is important to monitor for any signs of allergic reactions, which may require immediate medical attention.

Precautions & Warnings

  • Elocta should be handled with care and stored according to the manufacturer's instructions to maintain its efficacy. It is crucial to follow proper administration techniques to minimize the risk of infection or other complications. Patients should be aware of the potential for allergic reactions and seek medical advice if any severe symptoms occur. Regular monitoring by a healthcare provider is recommended to ensure the medication is working effectively.

Avoid Interactions

  • Elocta may interact with certain medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol and other substances that affect blood clotting should be used with caution. Always consult with a healthcare professional before starting any new medication while using Elocta.

Frequently Asked Questions

Elocta is used to treat and prevent bleeding episodes in individuals with hemophilia A, a condition characterized by a deficiency in clotting factor VIII.

Elocta is administered intravenously, typically by a healthcare professional or a trained individual.

Common side effects may include mild reactions at the injection site, headaches, nausea, and dizziness.

Yes, Elocta can be used to manage bleeding during surgical procedures in individuals with hemophilia A.

Elocta is approved for use in both adults and children with hemophilia A, but it should be administered under the guidance of a healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Efmoroctocog Alfa

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT